Fuji Corporation has transferred all shares of its equity-method affiliate Lady Pharmacy Co., Ltd., and expects to record extraordinary income of \u00a58,189 million from sale of investment securities in the consolidated financial results for the fourth quarter of fiscal 2026 ending February, as well as extraordinary income of \u00a517,447 million from sale of equity-method affiliate shares in its non-consolidated financial results.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8278","jir_company_name":"Fuji Corporation","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-01-08","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/8278-20260108-03.pdf","jir_short_summary":"Fuji Corporation has transferred all shares of its equity-method affiliate Lady Pharmacy Co., Ltd., and expects to record extraordinary income of \u00a58,189 million from sale of investment securities in the consolidated financial results for the fourth quarter of fiscal 2026 ending February, as well as extraordinary income of \u00a517,447 million from sale of equity-method affiliate shares in its non-consolidated financial results.","jir_summary":"### Overview of Transfer of Equity-Method Affiliate Shares\nFuji Corporation has transferred all shares held in its equity-method affiliate Lady Pharmacy Co., Ltd. As a result, an extraordinary gain of \u00a58,189 million from the sale of investment securities is expected to be recorded in the consolidated financial results for the fourth quarter of fiscal 2026 ending February, and an extraordinary gain of \u00a517,447 million from the sale of equity-method affiliate shares is expected in the non-consolidated financial results.\n\n### Impact on Earnings Guidance\nThe recognition of this extraordinary income from the share transfer has already been reflected in the consolidated earnings guidance disclosed in the financial summary for the third quarter of fiscal 2026 ending February. The impact of the transfer has been incorporated into the earnings forecast, and the effect on future earnings is expected to be limited.","jir_financial_highlights":"Gain on Sales of Investment Securities (Extraordinary Income): \u00a58,189 million (Unknown)\nGain on Sales of Equity-Method Affiliate Shares (Extraordinary Income): \u00a517,447 million (Unknown)","jir_category":"","jir_hashtags":"#FujiCorporation, #GeneralIR, #ShareTransfer","jir_key_figures":"Gain on Sales of Investment Securities (Extraordinary Income): \u00a58,189 million (expected in consolidated financial results for fourth quarter of fiscal 2026 ending February)\nGain on Sales of Equity-Method Affiliate Shares (Extraordinary Income): \u00a517,447 million (expected in non-consolidated financial results for fiscal 2026 ending February)\nShare Transfer Date: 2025-11-20 (disclosed)","jir_meta_title":"Fuji Corporation Records Extraordinary Income of \u00a58,189 Million and \u00a517,447 Million from Transfer of Lady Pharmacy Shares","jir_meta_description":"Fuji Corporation plans to record extraordinary income of \u00a58,189 million in the consolidated fourth quarter and \u00a517,447 million in non-consolidated results for the fiscal year ending February 2026, following the full transfer of shares in equity-method affiliate Lady Pharmacy. Earnings guidance has been updated accordingly.","jir_og_title":"Fuji Corporation Announces Extraordinary Income from Transfer of Lady Pharmacy Shares","jir_og_description":"Following the transfer of shares in Lady Pharmacy, Fuji Corporation will record extraordinary income in fiscal 2026 ending February. The impact has already been reflected in earnings guidance.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9070,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-16425","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n